Sino Biopharmaceutical Ltd Financials

Market Capitalization HK$100.20 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	50.91
Forward PE	31.11
Price to Sales TTM	HK$3.47
Price to Book MRQ	HK$3.14
Enterprise to Revenue	3.46
Enterprise to EBITDA	14.51

Financial Reports as of Jun. 30, 2021

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2021-06-30
Profit Margin	12.12%
Operating Margin	13.08%
Return on Assets TTM	5.62%
Return on Equity TTM	11.82%

Income Statement

Revenue TTM	HK$31,596,897,194
Revenue per Share TTM	HK$1.58
Quarterly Revenue Growth	-1.83%
Gross Profit TTM	HK$25,755,873,409
EBITDA	HK$13,205,607,000
Net Income to Common TTM	HK$2,101,305,826
Diluted EPS TTM	HK$0.11
Quarterly Earnings Growth YoY	10.66%

Balance Sheet

Total Cash MRQ	HK$16,219,685,144
Total Cash per Share MRQ	HK$0.83
Total Debt MRQ	HK$
Total Debt to Equity MRQ	22.70
Current Ratio MRQ	1.26
Book Value per Share MRQ	HK$1.78

Cash Flow

Operating Cash Flow TTM	HK$7,240,910,211
Levered Free Cash Flow TTM	HK$4,274,263,293

1177 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	18,205,469,187
Float Shares	8,857,941,019
Avg 10 Volume	148,235,581
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.22%
% Held by Institutions	16.62%

Stock Price Summary

Beta	0.71
Fifty Two Week Low	HK$2.67
Fifty Two Week High	HK$5.78
Fifty Two Week Change	50.18%
Day 50 MA	HK$4.48
Day 200 MA	HK$3.64

Dividends and Splits

Forward Annual Dividend Rate	HK$0.08
Forward Annual Dividend Yield	1.43%
Trailing Annual Dividend Rate	HK$0.07
Trailing Annual Dividend Yield	1.25%
Payout Ratio	52.42%
Dividend Date
Ex Dividend Date	2025-06-16
Last Split Factor
Last Split Date	2020-07-20